Legal Marijuana Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Legal Marijuana Market, Marijuana Type

7.1.  Legal Marijuana Market, Marijuana Type 2020-2030

7.1.1.    Medical

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Adult Use

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Legal Marijuana Market, By Product Type

8.1.  Legal Marijuana Market, By Product Type, 2020-2030

8.1.1.    Flower

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Oil

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Legal Marijuana Market, By Medical Application

9.1.  Legal Marijuana Market, By Medical Application, 2020-2030

9.1.1.    Chronic Pain

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Mental Disorders

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cancer

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Others

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Legal Marijuana Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, Marijuana Type (2016-2030)

10.1.2.  Market Revenue and Forecast, By Product Type (2016-2030)

10.1.3.  Market Revenue and Forecast, By Medical Application (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, Marijuana Type (2016-2030)

10.2.2.  Market Revenue and Forecast, By Product Type (2016-2030)

10.2.3.  Market Revenue and Forecast, By Medical Application (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, Marijuana Type (2016-2030)

10.3.2.  Market Revenue and Forecast, By Product Type (2016-2030)

10.3.3.  Market Revenue and Forecast, By Medical Application (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, Marijuana Type (2016-2030)

10.4.2.  Market Revenue and Forecast, By Product Type (2016-2030)

10.4.3.  Market Revenue and Forecast, By Medical Application (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, Marijuana Type (2016-2030)

10.5.2.  Market Revenue and Forecast, By Product Type (2016-2030)

10.5.3.  Market Revenue and Forecast, By Medical Application (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, Marijuana Type (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Product Type (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Medical Application (2016-2030)

Chapter 11.  Company Profiles

11.1.              Canopy Growth Corporation

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Aurora Cannabis

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Aphria, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Tilray

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              ABcann Medicinals, Inc.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              The Cronos Group

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Maricann Group, Inc.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Organigram Holding, Inc.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Lexaria Corp.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms